Multi Barrier Reverse Convertible

Symbol: KYZGDU
ISIN: CH1385468983
Issuer:
UBS
Trade

Chart

    
    

SIX Structured Products trading

SIX Structured Products Bid Ask Notation
Price Time-delayed price
24.08.26
11:09:31
100.40 %
101.40 %
CHF
Volume
100,000
100,000
nominal
Trading hours for this product: 9:15 – 17:15

Performance

Closing prev. day 101.10
Diff. absolute / % -0.70 -0.69%

Determined prices

Last Price - Volume -
Time - Date -

More Product Information

Core Data

Name Multi Barrier Reverse Convertible
ISIN CH1385468983
Valor 138546898
Symbol KYZGDU
Quotation in percent Yes
Coupon p.a. 6.75%
Coupon Premium 6.31%
Coupon Yield 0.44%
Type Multi Barrier Reverse Convertibles
SVSP Code 1230
Barrier reached No
Exercise type American
Currency Swiss Franc
First Trading Date 23/10/2024
Date of maturity 23/10/2026
Last trading day 16/10/2026
Settlement Type Path-dependent
IRS 871m Not applicable
Currency safeguarded No
Pricing Clean
Issuer UBS

Key data

Ask Price (basis for calculation) 101.3000
Maximum yield -0.19%
Maximum yield p.a. -1.14%
Sideways yield -0.19%
Sideways yield p.a. -1.14%

market maker quality Date: 21/08/2026

Average Spread 0.99%
Last Best Bid Price 100.40 %
Last Best Ask Price 101.40 %
Last Best Bid Volume 100,000
Last Best Ask Volume 100,000
Average Buy Volume 100,000
Average Sell Volume 100,000
Average Buy Value 100,389 CHF
Average Sell Value 101,389 CHF
Spreads Availability Ratio 99.61%
Quote Availability 99.61%

Underlyings

Name Novartis AG Swisscom N Roche PS
ISIN CH0012005267 CH0008742519 CH1499059983
Price 126.8600 CHF 633.50 CHF 371.00 CHF
Date 24/08/26 12:19 24/08/26 12:16 24/08/26 12:18
Cap 100.80 CHF 566.00 CHF 269.60 CHF
Distance to Cap 26.34 67 101.7
Distance to Cap in % 20.72% 10.58% 27.39%
Is Cap Level reached No No No
Barrier 70.56 CHF 396.20 CHF 188.72 CHF
Distance to Barrier 56.58 236.8 182.58
Distance to Barrier in % 44.50% 37.41% 49.17%
Is Barrier reached No No No

Please wait...
The data push was deactivated due to a timeout. Please click "Refresh page" to continue.